venBio Global Strategic Fund II L.P. is 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI). They have made 10 open-market trades across 5 companies since 2017, most recently 2022-05-12.
CIK 0001634632
3 open-market purchases totalling $13.0M since 2017, against 7 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | — | — |
| Avg Move | +3.5% | — | — |
| Scored | 7 | 4 | 4 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMPI | SELL | 2022-05-10 | 2022-05-12 | $10.39 | $3.2M | +0.6% | N/A | N/A |
| CMPI | SELL | 2022-05-05 | 2022-05-09 | $10.37 | $1.6M | +1.0% | N/A | N/A |
| CMPI | SELL | 2022-04-27 | 2022-04-29 | $10.38 | $3.2M | -0.1% | N/A | N/A |
| IMPL | BUY | 2021-04-27 | 2021-04-29 | $15.00 | $6.8M | -3.6% | -34.4% | -16.5% |
| AKRO | SELL | 2020-07-01 | 2020-07-06 | $34.40 | $8.0M | +4.2% | +0.6% | -16.5% |
| AKRO | SELL | 2020-02-06 | 2020-02-10 | $27.03 | $330K | -16.6% | -22.4% | -18.8% |
| AKRO | SELL | 2020-01-08 | 2020-01-10 | $19.86 | $623K | +20.1% | +32.0% | +18.4% |
| AKRO | SELL | 2020-01-06 | 2020-01-08 | $19.78 | $2.3M | +15.6% | +31.4% | -0.3% |
| MNLO | BUY | 2018-01-25 | 2018-01-29 | $17.00 | $4.5M | +10.1% | +3.9% | -75.8% |
| APLS | BUY | 2017-11-13 | 2017-11-13 | $14.00 | $1.8M | -4.2% | -10.5% | +5.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.